speb/financial-data huggingface dataset:
EPSN balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 12062053.00
EPSN balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 12062053.00
EPSN balance_sheet (quarterly, 2025-09-30) — Non Current Prepaid Assets: 4673.00
EPSN income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 3266613.00
EPSN income_statement (quarterly, 2025-09-30) — Normalized Income: 445156.12
EPSN cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 3965950.00
EPSN cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -964307.00
EPSN income_statement (quarterly, 2025-09-30) — Operating Income: 606005.00
EPSN income_statement (quarterly, 2025-09-30) — Operating Revenue: 8981459.00
EPSN balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 22058574.00
EPSN balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 965970.00
EPSN balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 9864979.00
EPSN income_statement (quarterly, 2025-09-30) — Other Gand A: 2467785.00
EPSN income_statement (quarterly, 2025-09-30) — Other Income Expense: 969559.00
EPSN cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 807648.00
EPSN balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 470000.00
EPSN income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 5252.00
EPSN balance_sheet (quarterly, 2025-09-30) — Other Payable: 2460410.00
EPSN balance_sheet (quarterly, 2025-09-30) — Other Properties: 43540301.00
EPSN balance_sheet (quarterly, 2025-09-30) — Other Receivables: 219124.00
EPSN balance_sheet (quarterly, 2025-09-30) — Payables: 6980939.00
EPSN balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 9077614.00
EPSN balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 726213.00
EPSN balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
EPSN balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 0.00
EPSN income_statement (quarterly, 2025-09-30) — Pretax Income: 1648792.00
EPSN cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: 0.00
EPSN cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: 40876.00
EPSN balance_sheet (quarterly, 2025-09-30) — Receivables: 4515199.00
EPSN income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 5531056.00
EPSN income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 2570462.00
EPSN cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
EPSN balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -38995173.00
EPSN income_statement (quarterly, 2025-09-30) — Salaries And Wages: 376613.00
EPSN cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 0.00
EPSN income_statement (quarterly, 2025-09-30) — Selling General And Administration: 2844398.00
EPSN balance_sheet (quarterly, 2025-09-30) — Share Issued: 22058574.00
EPSN income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
EPSN cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 376613.00
EPSN balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 100218033.00
EPSN balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 100218033.00
EPSN income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 337168.12
EPSN income_statement (quarterly, 2025-09-30) — Tax Provision: 576497.00
EPSN income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.35
EPSN balance_sheet (quarterly, 2025-09-30) — Total Assets: 126293005.00
EPSN balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 100218033.00
EPSN balance_sheet (quarterly, 2025-09-30) — Total Debt: 387062.00
EPSN balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 100218033.00
EPSN income_statement (quarterly, 2025-09-30) — Total Expenses: 8375454.00
EPSN balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 26074972.00
EPSN balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 107156482.00
EPSN balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 16150346.00
EPSN income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 606005.00
EPSN balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 1556724.00
EPSN income_statement (quarterly, 2025-09-30) — Total Unusual Items: 964307.00
EPSN income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 964307.00
EPSN balance_sheet (quarterly, 2025-09-30) — Working Capital: 9211897.00
EPSN income_statement (annual, 2025-12-31) — +Operating Expense: 8913152.00
EPSN income_statement (quarterly, 2025-12-31) — +Operating Expense: 2016782.00
EPSN income_statement (annual, 2025-12-31) — +Total Revenue: 51587556.00
EPSN income_statement (quarterly, 2025-12-31) — +Total Revenue: 14818224.00
EPSN balance_sheet (annual, 2025-12-31) — Accounts Payable: 11148050.00
EPSN balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 11148050.00
EPSN balance_sheet (annual, 2025-12-31) — Accounts Receivable: 12156210.00
EPSN balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 12156210.00
EPSN balance_sheet (annual, 2025-12-31) — Accrued Interest Receivable: 0.00
EPSN balance_sheet (quarterly, 2025-12-31) — Accrued Interest Receivable: 0.00
EPSN balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -169108280.00
EPSN balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -169108280.00
EPSN balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 13863824.00
EPSN balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 13863824.00
EPSN cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 3936669.00
EPSN cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 1260000.00
EPSN income_statement (annual, 2025-12-31) — Basic Average Shares: 23020672.00
EPSN income_statement (annual, 2025-12-31) — Basic EPS: -0.25
EPSN cash_flow (annual, 2025-12-31) — Beginning Cash Position: 6989793.00
EPSN cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 13236167.00
EPSN balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 4621681.00
EPSN balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 4621681.00
EPSN cash_flow (annual, 2025-12-31) — Capital Expenditure: -15394881.00
EPSN cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -4064686.00
EPSN balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 611546.00
EPSN balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 611546.00
EPSN balance_sheet (annual, 2025-12-31) — Capital Stock: 154274125.00
EPSN balance_sheet (quarterly, 2025-12-31) — Capital Stock: 154274125.00
EPSN balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 8959954.00
EPSN balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 8959954.00
EPSN balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 8959954.00
EPSN balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 8959954.00
EPSN cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -5998223.00
EPSN cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -1868336.00
EPSN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 43682920.00
EPSN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 47812807.00
EPSN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -61642742.00
EPSN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -51290591.00
EPSN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 20619683.00
EPSN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -277017.00
EPSN cash_flow (annual, 2025-12-31) — Change In Account Payable: -2940888.00
EPSN cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -2510003.00
EPSN cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -10365.00
EPSN cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 181122.00
EPSN cash_flow (annual, 2025-12-31) — Change In Payable: -2940888.00
EPSN cash_flow (quarterly, 2025-12-31) — Change In Payable: -5042689.00
EPSN cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -2940888.00
EPSN cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -5042689.00
EPSN cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -1973348.00
EPSN cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -1973348.00
EPSN cash_flow (annual, 2025-12-31) — Change In Receivables: -1588383.00
EPSN cash_flow (quarterly, 2025-12-31) — Change In Receivables: -2916906.00
EPSN cash_flow (annual, 2025-12-31) — Change In Working Capital: -6512984.00
EPSN cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -9751821.00
EPSN cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -1588383.00
EPSN cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -2916906.00
EPSN cash_flow (annual, 2025-12-31) — Changes In Cash: 2659861.00
EPSN cash_flow (quarterly, 2025-12-31) — Changes In Cash: -3754801.00
EPSN balance_sheet (annual, 2025-12-31) — Common Stock: 154274125.00
EPSN balance_sheet (quarterly, 2025-12-31) — Common Stock: 154274125.00
EPSN cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -5998223.00
EPSN cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -1868336.00
EPSN balance_sheet (annual, 2025-12-31) — Common Stock Equity: 124732354.00
EPSN balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 124732354.00
EPSN cash_flow (annual, 2025-12-31) — Common Stock Payments: 0.00
EPSN cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
EPSN income_statement (annual, 2025-12-31) — Cost Of Revenue: 27050681.00
EPSN income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 8456985.00
EPSN balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 2706978.00
EPSN balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 2706978.00
EPSN balance_sheet (annual, 2025-12-31) — Current Assets: 32583778.00
EPSN balance_sheet (quarterly, 2025-12-31) — Current Assets: 32583778.00
EPSN balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 271494.00
EPSN balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 271494.00
EPSN balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 271494.00
EPSN balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 271494.00
EPSN balance_sheet (annual, 2025-12-31) — Current Liabilities: 24961495.00
EPSN balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 24961495.00
EPSN cash_flow (annual, 2025-12-31) — Deferred Income Tax: 117008.00
EPSN cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 793531.00
EPSN cash_flow (annual, 2025-12-31) — Deferred Tax: 117008.00
EPSN cash_flow (quarterly, 2025-12-31) — Deferred Tax: 793531.00
EPSN cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 12170320.00
EPSN cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 2922347.00
EPSN income_statement (annual, 2025-12-31) — Diluted Average Shares: 23020672.00
EPSN income_statement (annual, 2025-12-31) — Diluted EPS: -0.25
EPSN income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -5798863.00
EPSN income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -12438653.00
EPSN income_statement (annual, 2025-12-31) — EBIT: -4811972.00
EPSN income_statement (quarterly, 2025-12-31) — EBIT: -15579923.00
EPSN income_statement (annual, 2025-12-31) — EBITDA: 7358348.00
EPSN income_statement (quarterly, 2025-12-31) — EBITDA: -12657576.00
EPSN cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -136700.00
EPSN cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 31588.00
EPSN cash_flow (annual, 2025-12-31) — End Cash Position: 9512954.00
EPSN cash_flow (quarterly, 2025-12-31) — End Cash Position: 9512954.00
EPSN balance_sheet (annual, 2025-12-31) — Financial Assets: 1154936.00
EPSN balance_sheet (quarterly, 2025-12-31) — Financial Assets: 1154936.00
EPSN cash_flow (annual, 2025-12-31) — Financing Cash Flow: 43682920.00
EPSN cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 47812807.00
EPSN cash_flow (annual, 2025-12-31) — Free Cash Flow: 5224802.00
EPSN cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -4341703.00
EPSN cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -5500486.00
EPSN cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -3424486.00
EPSN cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 19256530.00
EPSN income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: -19256530.00
EPSN income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 5500486.00
EPSN income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 3424486.00
EPSN balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 9896567.00
EPSN balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 9896567.00
EPSN income_statement (annual, 2025-12-31) — General And Administrative Expense: 8913152.00
EPSN income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 2016782.00
EPSN balance_sheet (annual, 2025-12-31) — Gross PPE: 362035416.00
EPSN balance_sheet (quarterly, 2025-12-31) — Gross PPE: 362035416.00
EPSN income_statement (annual, 2025-12-31) — Gross Profit: 24536875.00
EPSN income_statement (quarterly, 2025-12-31) — Gross Profit: 6361239.00
EPSN balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 2694340.00
EPSN balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 2694340.00
EPSN income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 3936669.00
EPSN income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 1260000.00
EPSN cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 2176984.00
EPSN cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: -22724.00
EPSN income_statement (annual, 2025-12-31) — Interest Expense: 624160.00
EPSN income_statement (quarterly, 2025-12-31) — Interest Expense: 580377.00
EPSN income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 624160.00
EPSN income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 580377.00
EPSN income_statement (annual, 2025-12-31) — Interest Income: 188369.00
EPSN income_statement (quarterly, 2025-12-31) — Interest Income: 70929.00
EPSN income_statement (annual, 2025-12-31) — Interest Income Non Operating: 188369.00
EPSN income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 70929.00
EPSN cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 9935.00
EPSN cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 0.00
EPSN balance_sheet (annual, 2025-12-31) — Invested Capital: 175232354.00
EPSN balance_sheet (quarterly, 2025-12-31) — Invested Capital: 175232354.00
EPSN cash_flow (annual, 2025-12-31) — Investing Cash Flow: -61642742.00
EPSN cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -51290591.00
EPSN cash_flow (annual, 2025-12-31) — Issuance Of Debt: 50500000.00
EPSN balance_sheet (annual, 2025-12-31) — Land And Improvements: 1231965.00
EPSN balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 1231965.00
EPSN balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 340052.00
EPSN balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 340052.00
EPSN balance_sheet (annual, 2025-12-31) — Long Term Debt: 50500000.00
EPSN balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 50500000.00
EPSN balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 50840052.00
EPSN balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 50840052.00
EPSN cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 50500000.00
EPSN balance_sheet (annual, 2025-12-31) — Long Term Provisions: 7437960.00
EPSN balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 7437960.00
EPSN cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -49754846.00
EPSN cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
EPSN cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
EPSN balance_sheet (annual, 2025-12-31) — Net Debt: 41540046.00
EPSN balance_sheet (quarterly, 2025-12-31) — Net Debt: 41540046.00
EPSN income_statement (annual, 2025-12-31) — Net Income: -5798863.00
EPSN income_statement (quarterly, 2025-12-31) — Net Income: -12438653.00
EPSN income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -5798863.00
EPSN income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -12438653.00
EPSN income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -5798863.00
EPSN income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -12438653.00
EPSN income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -5798863.00
EPSN income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -12438653.00
EPSN income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -5798863.00
EPSN income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -12438653.00
EPSN cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -5798863.00
EPSN cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -12438653.00
EPSN income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -5798863.00
EPSN income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -12438653.00
EPSN income_statement (annual, 2025-12-31) — Net Interest Income: -435791.00
EPSN income_statement (quarterly, 2025-12-31) — Net Interest Income: -509448.00
EPSN cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 0.00
EPSN cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 0.00
EPSN cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 50500000.00
EPSN cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 50500000.00
EPSN income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -435791.00
EPSN income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -509448.00
EPSN cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -818857.00
EPSN cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 736497.00
EPSN cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -241547.00
EPSN balance_sheet (annual, 2025-12-31) — Net PPE: 192927136.00
EPSN balance_sheet (quarterly, 2025-12-31) — Net PPE: 192927136.00
EPSN cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -12624393.00
EPSN cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -1294198.00
EPSN balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 124732354.00
EPSN balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 124732354.00
EPSN balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 774347.00
EPSN balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 774347.00
EPSN balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 12855585.00
EPSN balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 12855585.00
EPSN balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 12855585.00
EPSN balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 12855585.00
EPSN balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 246220.00
EPSN balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 246220.00
EPSN income_statement (annual, 2025-12-31) — Normalized EBITDA: 27998968.00
EPSN income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 7382375.00
EPSN income_statement (annual, 2025-12-31) — Normalized Income: 10507226.80
EPSN income_statement (quarterly, 2025-12-31) — Normalized Income: 2986184.20
EPSN cash_flow (annual, 2025-12-31) — Operating Cash Flow: 20619683.00
EPSN cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -277017.00
EPSN cash_flow (annual, 2025-12-31) — Operating Gains Losses: 13756044.00
EPSN cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 15832044.00
EPSN income_statement (annual, 2025-12-31) — Operating Income: 15623723.00
EPSN income_statement (quarterly, 2025-12-31) — Operating Income: 4344457.00
EPSN income_statement (annual, 2025-12-31) — Operating Revenue: 51587556.00
EPSN income_statement (quarterly, 2025-12-31) — Operating Revenue: 14818224.00
EPSN balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 30239980.00
EPSN balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 30239980.00
EPSN balance_sheet (annual, 2025-12-31) — Other Current Assets: 1847672.00
EPSN balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 1847672.00
EPSN balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 9896567.00
EPSN balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 9896567.00
EPSN income_statement (annual, 2025-12-31) — Other Gand A: 7168235.00
EPSN income_statement (quarterly, 2025-12-31) — Other Gand A: 1420154.00
EPSN income_statement (annual, 2025-12-31) — Other Income Expense: -20624064.00
EPSN income_statement (quarterly, 2025-12-31) — Other Income Expense: -19995309.00
EPSN cash_flow (annual, 2025-12-31) — Other Non Cash Items: 1206572.00
EPSN cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 508907.00
EPSN balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 553000.00
EPSN balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 553000.00
EPSN income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 16556.00
EPSN income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 44642.00
EPSN balance_sheet (annual, 2025-12-31) — Other Payable: 9778669.00
EPSN balance_sheet (quarterly, 2025-12-31) — Other Payable: 9778669.00
EPSN balance_sheet (annual, 2025-12-31) — Other Properties: 43540389.00
EPSN balance_sheet (quarterly, 2025-12-31) — Other Properties: 43540389.00
EPSN balance_sheet (annual, 2025-12-31) — Other Receivables: 3976291.00
EPSN balance_sheet (quarterly, 2025-12-31) — Other Receivables: 3976291.00
EPSN balance_sheet (annual, 2025-12-31) — Payables: 20926719.00
EPSN balance_sheet (quarterly, 2025-12-31) — Payables: 20926719.00
EPSN balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 23633697.00
EPSN balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 23633697.00
EPSN balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1056304.00
EPSN balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1056304.00
EPSN balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
EPSN balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
EPSN balance_sheet (annual, 2025-12-31) — Prepaid Assets: 2949311.00
EPSN balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 2949311.00
EPSN income_statement (annual, 2025-12-31) — Pretax Income: -5436132.00
EPSN income_statement (quarterly, 2025-12-31) — Pretax Income: -16160300.00
EPSN cash_flow (annual, 2025-12-31) — Purchase Of Business: -49754846.00
EPSN cash_flow (annual, 2025-12-31) — Purchase Of Investment: 0.00
EPSN cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: 0.00
EPSN cash_flow (annual, 2025-12-31) — Purchase Of PPE: -15394881.00
EPSN cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -4064686.00
EPSN balance_sheet (annual, 2025-12-31) — Receivables: 16132501.00
EPSN balance_sheet (quarterly, 2025-12-31) — Receivables: 16132501.00
EPSN income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 27050681.00
EPSN income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 8456985.00
EPSN income_statement (annual, 2025-12-31) — Reconciled Depreciation: 12170320.00
EPSN income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 2922347.00
EPSN cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: 0.00
EPSN cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
EPSN income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 2947907.00
EPSN balance_sheet (annual, 2025-12-31) — Retained Earnings: -53302162.00
EPSN balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -53302162.00
EPSN income_statement (annual, 2025-12-31) — Salaries And Wages: 1744917.00
EPSN income_statement (quarterly, 2025-12-31) — Salaries And Wages: 596628.00
EPSN cash_flow (annual, 2025-12-31) — Sale Of Investment: 0.00
EPSN cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 0.00
EPSN cash_flow (annual, 2025-12-31) — Sale Of PPE: 2770488.00
EPSN income_statement (annual, 2025-12-31) — Selling General And Administration: 8913152.00
EPSN income_statement (quarterly, 2025-12-31) — Selling General And Administration: 2016782.00
EPSN balance_sheet (annual, 2025-12-31) — Share Issued: 30239980.00
EPSN balance_sheet (quarterly, 2025-12-31) — Share Issued: 30239980.00
EPSN income_statement (annual, 2025-12-31) — Special Income Charges: -26141106.00
EPSN income_statement (quarterly, 2025-12-31) — Special Income Charges: -23464437.00
EPSN cash_flow (annual, 2025-12-31) — Stock Based Compensation: 1744917.00
EPSN cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 596628.00
EPSN balance_sheet (annual, 2025-12-31) — Stockholders Equity: 124732354.00
EPSN balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 124732354.00
EPSN balance_sheet (annual, 2025-12-31) — Tangible Book Value: 124732354.00
EPSN balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 124732354.00
EPSN income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -4334530.20
EPSN income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -4615113.80
EPSN income_statement (annual, 2025-12-31) — Tax Provision: 362731.00
EPSN income_statement (quarterly, 2025-12-31) — Tax Provision: -3721647.00
EPSN income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
EPSN income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.23
EPSN balance_sheet (annual, 2025-12-31) — Total Assets: 228239417.00
EPSN balance_sheet (quarterly, 2025-12-31) — Total Assets: 228239417.00
EPSN balance_sheet (annual, 2025-12-31) — Total Capitalization: 175232354.00
EPSN balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 175232354.00
EPSN balance_sheet (annual, 2025-12-31) — Total Debt: 51111546.00
EPSN balance_sheet (quarterly, 2025-12-31) — Total Debt: 51111546.00
EPSN balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 124732354.00
EPSN balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 124732354.00
EPSN income_statement (annual, 2025-12-31) — Total Expenses: 35963833.00
EPSN income_statement (quarterly, 2025-12-31) — Total Expenses: 10473767.00
EPSN balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 103507063.00
EPSN balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 103507063.00
EPSN balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 195655639.00
EPSN balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 195655639.00
EPSN balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 78545568.00
EPSN balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 78545568.00
EPSN income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -10517383.00
EPSN income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -19119980.00
EPSN income_statement (annual, 2025-12-31) — Total Unusual Items: -20640620.00
EPSN income_statement (quarterly, 2025-12-31) — Total Unusual Items: -20039951.00
EPSN income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -20640620.00
EPSN income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -20039951.00
EPSN balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 7411971.00
EPSN balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 7411971.00
EPSN balance_sheet (annual, 2025-12-31) — Working Capital: 7622283.00
EPSN balance_sheet (quarterly, 2025-12-31) — Working Capital: 7622283.00
EPSN income_statement (quarterly, 2026-03-31) — +Operating Expense: 3925669.00
EPSN income_statement (quarterly, 2026-03-31) — +Total Revenue: 25595787.00
EPSN balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 8159934.00
EPSN balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 14464092.00
EPSN balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -171877173.00
EPSN balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 14411351.00
EPSN cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 0.00
EPSN income_statement (quarterly, 2026-03-31) — Basic Average Shares: 30239980.00
EPSN income_statement (quarterly, 2026-03-31) — Basic EPS: 0.02
EPSN cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 9512954.00
EPSN balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 4507086.00
EPSN cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -4264748.00
EPSN balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 542836.00
EPSN balance_sheet (quarterly, 2026-03-31) — Capital Stock: 154274125.00
EPSN balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 7912858.00
EPSN balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 7912858.00
EPSN cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -1884373.00
EPSN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -6884373.00
EPSN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -4262923.00
EPSN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 10102519.00
EPSN cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -1813998.00
EPSN cash_flow (quarterly, 2026-03-31) — Change In Income Tax Payable: 0.00
EPSN cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 112036.00
EPSN cash_flow (quarterly, 2026-03-31) — Change In Payable: -1813998.00
EPSN cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -1813998.00
EPSN cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -10164.00
EPSN cash_flow (quarterly, 2026-03-31) — Change In Receivables: -661928.00
EPSN cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: 0.00
EPSN cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -2374054.00
EPSN cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -661928.00
EPSN cash_flow (quarterly, 2026-03-31) — Changes In Cash: -1044777.00
EPSN balance_sheet (quarterly, 2026-03-31) — Common Stock: 154274125.00
EPSN cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -1884373.00
EPSN balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 124122614.00
EPSN income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 10792098.00
EPSN balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 3504350.00
EPSN balance_sheet (quarterly, 2026-03-31) — Current Assets: 29781580.00
EPSN balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 271790.00
EPSN balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 271790.00
EPSN balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 27628535.00
EPSN cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 265205.00
EPSN cash_flow (quarterly, 2026-03-31) — Deferred Tax: 265205.00
EPSN cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 3002339.00
EPSN balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 810629.00
EPSN income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 30262466.00
EPSN income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.02
EPSN income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 729425.00
EPSN income_statement (quarterly, 2026-03-31) — EBIT: 1938742.00
EPSN income_statement (quarterly, 2026-03-31) — EBITDA: 4941081.00
EPSN cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -2319.00
EPSN cash_flow (quarterly, 2026-03-31) — End Cash Position: 8465858.00
EPSN balance_sheet (quarterly, 2026-03-31) — Financial Assets: 185056.00
EPSN cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -6884373.00
EPSN cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 5837771.00
EPSN cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 8929829.00
EPSN income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -8929829.00
EPSN balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 9894248.00
EPSN income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 3925669.00
EPSN balance_sheet (quarterly, 2026-03-31) — Gross PPE: 366806097.00
EPSN income_statement (quarterly, 2026-03-31) — Gross Profit: 14803689.00
EPSN balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 426255.00
EPSN income_statement (quarterly, 2026-03-31) — Impairment Of Capital Assets: 0.00
EPSN cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 10933.00
EPSN income_statement (quarterly, 2026-03-31) — Interest Expense: 941581.00
EPSN income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 941581.00
EPSN income_statement (quarterly, 2026-03-31) — Interest Income: 45543.00
EPSN income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 45543.00
EPSN cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 42347.00
EPSN balance_sheet (quarterly, 2026-03-31) — Invested Capital: 169622614.00
EPSN cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -4262923.00
EPSN balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 1231965.00
EPSN balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 271046.00
EPSN balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 45500000.00
EPSN balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 45771046.00
EPSN cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -5000000.00
EPSN balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 7553458.00
EPSN balance_sheet (quarterly, 2026-03-31) — Net Debt: 37587142.00
EPSN income_statement (quarterly, 2026-03-31) — Net Income: 729425.00
EPSN income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 729425.00
EPSN income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 729425.00
EPSN income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 729425.00
EPSN income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 729425.00
EPSN cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 729425.00
EPSN income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 729425.00
EPSN income_statement (quarterly, 2026-03-31) — Net Interest Income: -896038.00
EPSN cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -5000000.00
EPSN cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -5000000.00
EPSN income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -896038.00
EPSN balance_sheet (quarterly, 2026-03-31) — Net PPE: 194928924.00
EPSN cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -4262923.00
EPSN balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 124122614.00
EPSN balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 724263.00
EPSN balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 13120790.00
EPSN balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 13120790.00
EPSN balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 246220.00
EPSN income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 13942330.00
EPSN income_statement (quarterly, 2026-03-31) — Normalized Income: 7313854.25
EPSN cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 10102519.00
EPSN cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 8929829.00
EPSN income_statement (quarterly, 2026-03-31) — Operating Income: 10878020.00
EPSN income_statement (quarterly, 2026-03-31) — Operating Revenue: 25595787.00
EPSN balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 30239980.00
EPSN balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 1688563.00
EPSN balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 3833399.00
EPSN balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 9894248.00
EPSN income_statement (quarterly, 2026-03-31) — Other Gand A: 3378142.00
EPSN income_statement (quarterly, 2026-03-31) — Other Income Expense: -8984821.00
EPSN cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -997752.00
EPSN balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 553000.00
EPSN income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 16428.00
EPSN balance_sheet (quarterly, 2026-03-31) — Other Payable: 11119413.00
EPSN balance_sheet (quarterly, 2026-03-31) — Other Properties: 43593370.00
EPSN balance_sheet (quarterly, 2026-03-31) — Other Receivables: 2330337.00
EPSN balance_sheet (quarterly, 2026-03-31) — Payables: 19279347.00
EPSN balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 22783697.00
EPSN balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 739649.00
EPSN balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
EPSN balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 2959475.00
EPSN income_statement (quarterly, 2026-03-31) — Pretax Income: 997161.00
EPSN cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -4264748.00
EPSN balance_sheet (quarterly, 2026-03-31) — Receivables: 16794429.00
EPSN income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 10792098.00
EPSN income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 3002339.00
EPSN cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -5000000.00
EPSN income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 71420.00
EPSN balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -54457110.00
EPSN income_statement (quarterly, 2026-03-31) — Salaries And Wages: 547527.00
EPSN cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 1825.00
EPSN income_statement (quarterly, 2026-03-31) — Selling General And Administration: 3925669.00
EPSN balance_sheet (quarterly, 2026-03-31) — Share Issued: 30239980.00
EPSN income_statement (quarterly, 2026-03-31) — Special Income Charges: -71420.00
EPSN cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 547527.00
EPSN balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 124122614.00
EPSN balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 124122614.00
EPSN income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -2416819.75
EPSN income_statement (quarterly, 2026-03-31) — Tax Provision: 267736.00
EPSN income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.27
EPSN balance_sheet (quarterly, 2026-03-31) — Total Assets: 226419043.00
EPSN balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 169622614.00
EPSN balance_sheet (quarterly, 2026-03-31) — Total Debt: 46042836.00
EPSN balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 124122614.00
EPSN income_statement (quarterly, 2026-03-31) — Total Expenses: 14717767.00
EPSN balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 102296429.00
EPSN balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 196637463.00
EPSN balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 74667894.00
EPSN income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 10806600.00
EPSN income_statement (quarterly, 2026-03-31) — Total Unusual Items: -9001249.00
EPSN income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -9001249.00
EPSN balance_sheet (quarterly, 2026-03-31) — Tradeand Other Payables Non Current: 7411971.00
EPSN balance_sheet (quarterly, 2026-03-31) — Working Capital: 2153045.00
EPX.AX income_statement (annual, 2021-06-30) — +Operating Expense: 14767642.00
EPX.AX income_statement (annual, 2021-06-30) — +Total Revenue: 6077746.00
EPX.AX balance_sheet (annual, 2021-06-30) — Accounts Payable: 1332417.00
EPX.AX balance_sheet (annual, 2021-06-30) — Accounts Receivable: 2742097.00
EPX.AX balance_sheet (annual, 2021-06-30) — Accumulated Depreciation: -2488164.00
EPX.AX cash_flow (annual, 2021-06-30) — Beginning Cash Position: 265997.00
EPX.AX cash_flow (annual, 2021-06-30) — Capital Expenditure: -1757833.00
EPX.AX balance_sheet (annual, 2021-06-30) — Capital Lease Obligations: 573582.00
EPX.AX balance_sheet (annual, 2021-06-30) — Capital Stock: 36219410.00
EPX.AX balance_sheet (annual, 2021-06-30) — Cash And Cash Equivalents: 5300099.00
EPX.AX balance_sheet (annual, 2021-06-30) — Cash Cash Equivalents And Short Term Investments: 5348794.00
EPX.AX balance_sheet (annual, 2021-06-30) — Cash Financial: 5300099.00
EPX.AX cash_flow (annual, 2021-06-30) — Cash Flow From Continuing Financing Activities: 10221915.00
EPX.AX cash_flow (annual, 2021-06-30) — Cash Flow From Continuing Investing Activities: -1757833.00
EPX.AX cash_flow (annual, 2021-06-30) — Cash Flowsfromusedin Operating Activities Direct: -3429980.00
EPX.AX cash_flow (annual, 2021-06-30) — Changes In Cash: 5034102.00
EPX.AX cash_flow (annual, 2021-06-30) — Classesof Cash Payments: -12308053.00
EPX.AX cash_flow (annual, 2021-06-30) — Classesof Cash Receiptsfrom Operating Activities: 8891995.00
EPX.AX balance_sheet (annual, 2021-06-30) — Common Stock: 36219410.00
EPX.AX balance_sheet (annual, 2021-06-30) — Common Stock Equity: 8111236.00
EPX.AX cash_flow (annual, 2021-06-30) — Common Stock Issuance: 9125738.00
EPX.AX balance_sheet (annual, 2021-06-30) — Construction In Progress: 945030.00
EPX.AX income_statement (annual, 2021-06-30) — Cost Of Revenue: 208477.00
EPX.AX balance_sheet (annual, 2021-06-30) — Current Assets: 10248450.00
EPX.AX balance_sheet (annual, 2021-06-30) — Current Capital Lease Obligation: 412271.00
EPX.AX balance_sheet (annual, 2021-06-30) — Current Debt And Capital Lease Obligation: 412271.00
EPX.AX balance_sheet (annual, 2021-06-30) — Current Liabilities: 5370171.00
EPX.AX balance_sheet (annual, 2021-06-30) — Current Provisions: 65000.00
EPX.AX income_statement (annual, 2021-06-30) — Depreciation Amortization Depletion Income Statement: 546668.00
EPX.AX income_statement (annual, 2021-06-30) — Depreciation And Amortization In Income Statement: 546668.00
EPX.AX income_statement (annual, 2021-06-30) — Depreciation Income Statement: 546668.00
EPX.AX income_statement (annual, 2021-06-30) — EBIT: -11577956.00
EPX.AX income_statement (annual, 2021-06-30) — EBITDA: -11031288.00
EPX.AX balance_sheet (annual, 2021-06-30) — Employee Benefits: 32402.00
EPX.AX cash_flow (annual, 2021-06-30) — End Cash Position: 5300099.00
EPX.AX cash_flow (annual, 2021-06-30) — Financing Cash Flow: 10221915.00
EPX.AX balance_sheet (annual, 2021-06-30) — Finished Goods: 1409982.00
EPX.AX balance_sheet (annual, 2021-06-30) — Foreign Currency Translation Adjustments: -483513.00
EPX.AX cash_flow (annual, 2021-06-30) — Free Cash Flow: -5187813.00
EPX.AX balance_sheet (annual, 2021-06-30) — Gains Losses Not Affecting Retained Earnings: -15951313.00
EPX.AX income_statement (annual, 2021-06-30) — General And Administrative Expense: 9165422.00
EPX.AX balance_sheet (annual, 2021-06-30) — Gross PPE: 4725480.00
EPX.AX income_statement (annual, 2021-06-30) — Gross Profit: 5869269.00
EPX.AX income_statement (annual, 2021-06-30) — Interest Expense: 804722.00
EPX.AX income_statement (annual, 2021-06-30) — Interest Expense Non Operating: 804722.00
EPX.AX income_statement (annual, 2021-06-30) — Interest Income: 175680.00
EPX.AX income_statement (annual, 2021-06-30) — Interest Income Non Operating: 175680.00
EPX.AX cash_flow (annual, 2021-06-30) — Interest Paid Direct: -189602.00
EPX.AX cash_flow (annual, 2021-06-30) — Interest Paid Supplemental Data: 189602.00
EPX.AX cash_flow (annual, 2021-06-30) — Interest Received Direct: 175680.00
EPX.AX balance_sheet (annual, 2021-06-30) — Inventories Adjustments Allowances: -404050.00
EPX.AX balance_sheet (annual, 2021-06-30) — Inventory: 2080240.00
EPX.AX balance_sheet (annual, 2021-06-30) — Invested Capital: 8703670.00
EPX.AX cash_flow (annual, 2021-06-30) — Investing Cash Flow: -1757833.00
EPX.AX balance_sheet (annual, 2021-06-30) — Investments And Advances: 67938.00
EPX.AX cash_flow (annual, 2021-06-30) — Issuance Of Capital Stock: 9125738.00
EPX.AX cash_flow (annual, 2021-06-30) — Issuance Of Debt: 2542434.00
EPX.AX balance_sheet (annual, 2021-06-30) — Leases: 403502.00
EPX.AX balance_sheet (annual, 2021-06-30) — Long Term Capital Lease Obligation: 161311.00
EPX.AX balance_sheet (annual, 2021-06-30) — Long Term Debt: 592434.00
EPX.AX balance_sheet (annual, 2021-06-30) — Long Term Debt And Capital Lease Obligation: 753745.00
EPX.AX cash_flow (annual, 2021-06-30) — Long Term Debt Issuance: 2542434.00
EPX.AX cash_flow (annual, 2021-06-30) — Long Term Debt Payments: -1048359.00
EPX.AX balance_sheet (annual, 2021-06-30) — Machinery Furniture Equipment: 2021522.00
EPX.AX cash_flow (annual, 2021-06-30) — Net Common Stock Issuance: 9125738.00
EPX.AX income_statement (annual, 2021-06-30) — Net Income: -12156861.00
EPX.AX income_statement (annual, 2021-06-30) — Net Income Common Stockholders: -12156861.00
EPX.AX income_statement (annual, 2021-06-30) — Net Income Continuous Operations: -12156861.00
EPX.AX income_statement (annual, 2021-06-30) — Net Income From Continuing And Discontinued Operation: -12156861.00
EPX.AX income_statement (annual, 2021-06-30) — Net Income From Continuing Operation Net Minority Interest: -12156861.00
EPX.AX income_statement (annual, 2021-06-30) — Net Income Including Noncontrolling Interests: -12156861.00
EPX.AX income_statement (annual, 2021-06-30) — Net Interest Income: -707197.00
EPX.AX cash_flow (annual, 2021-06-30) — Net Issuance Payments Of Debt: 1494075.00
EPX.AX cash_flow (annual, 2021-06-30) — Net Long Term Debt Issuance: 1494075.00
EPX.AX income_statement (annual, 2021-06-30) — Net Non Operating Interest Income Expense: -707197.00
EPX.AX cash_flow (annual, 2021-06-30) — Net Other Financing Charges: -795796.00
EPX.AX balance_sheet (annual, 2021-06-30) — Net PPE: 2237316.00
EPX.AX cash_flow (annual, 2021-06-30) — Net PPE Purchase And Sale: -1757833.00
EPX.AX balance_sheet (annual, 2021-06-30) — Net Tangible Assets: 8111236.00
EPX.AX balance_sheet (annual, 2021-06-30) — Non Current Accounts Receivable: 916065.00
EPX.AX balance_sheet (annual, 2021-06-30) — Non Current Deferred Assets: 761035.00
EPX.AX balance_sheet (annual, 2021-06-30) — Non Current Deferred Taxes Assets: 761035.00
EPX.AX balance_sheet (annual, 2021-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 32402.00
EPX.AX income_statement (annual, 2021-06-30) — Normalized EBITDA: -11031288.00
EPX.AX income_statement (annual, 2021-06-30) — Normalized Income: -12156861.00
EPX.AX income_statement (annual, 2021-06-30) — Operating Income: -8898373.00
EPX.AX income_statement (annual, 2021-06-30) — Operating Revenue: 6077746.00
EPX.AX balance_sheet (annual, 2021-06-30) — Other Current Assets: 10318.00
EPX.AX balance_sheet (annual, 2021-06-30) — Other Current Liabilities: 51940.00
EPX.AX balance_sheet (annual, 2021-06-30) — Other Equity Adjustments: -15467800.00
EPX.AX income_statement (annual, 2021-06-30) — Other Income Expense: -2777108.00
EPX.AX balance_sheet (annual, 2021-06-30) — Other Inventories: 1040120.00
EPX.AX balance_sheet (annual, 2021-06-30) — Other Investments: 67938.00
EPX.AX balance_sheet (annual, 2021-06-30) — Other Non Current Assets: 1076870.00
EPX.AX income_statement (annual, 2021-06-30) — Other Non Operating Income Expenses: -2777108.00
EPX.AX income_statement (annual, 2021-06-30) — Other Operating Expenses: 2805485.00
EPX.AX balance_sheet (annual, 2021-06-30) — Other Payable: 2120485.00